Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection ; day:13 ; month:10 ; year:2023 ; pages:1-4
Cardiovascular drugs and therapy ; (13.10.2023), 1-4
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10557-023-07512-6
- URN
-
urn:nbn:de:101:1-2024010308365044196923
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hammer, Andreas
- Niessner, Alexander
- Sulzgruber, Patrick
- SpringerLink (Online service)
Other Objects (12)
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Erythropoietin and renal protection
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
SGLT2 and cancer
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise
Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi‐Bickel syndrome with empagliflozin
Neuroimmune system-mediated renal protection mechanisms
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Erythropoietin and renal protection
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
SGLT2 and cancer
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise
Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi‐Bickel syndrome with empagliflozin
Neuroimmune system-mediated renal protection mechanisms
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Erythropoietin and renal protection
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
SGLT2 and cancer
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise
Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi‐Bickel syndrome with empagliflozin